Bioharvest Sciences Inc (BHST) 13F Positioning & Ownership Changes (Q2 2026)

BHST ranks #8522 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

19 institutions disclose a position in BHST, but none treat it as a major bet — even Silverberg Bernstein Capital Management LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Alyeska Investment Group, L.P. has trimmed its BHST position for two straight quarters, cutting it by $2.3M while still holding $1.7M.

BHST reported a net loss of $11.1M in its latest fiscal year.

• Not yet profitable — net loss of $11.1M in the latest fiscal year
• Revenue grew 37.0% year over year
• Net income improved year over year, from -$12.9M to -$11.1M
• Operating cash flow was negative, using $7.2M in cash
• Current ratio of 3.97x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.87x equity — within a conventional range